Patents by Inventor Atsushi OSE

Atsushi OSE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for preventing or treating osteoporosis, characterized by administering teriparatide or salt thereof at a frequency of twice a week
    Patent number: 11541104
    Abstract: [Problems] To provide a method for treating and/or preventing osteoporosis with teriparatide or a salt thereof, the method having excellent safety and/or efficacies. [Solving Means] A method for treating and/or preventing osteoporosis in which teriparatide or a salt thereof is an active ingredient, including administering teriparatide or a salt thereof in a unit dose of 28.2 ?g at a frequency of twice a week.
    Type: Grant
    Filed: May 7, 2021
    Date of Patent: January 3, 2023
    Assignee: ASAHI KASEI PHARMA CORPORATION
    Inventors: Takeshi Minamida, Ryo Kato, Akira Koike, Atsushi Ose, Akihiro Kitami, Takashi Makiyama, Hikaru Yamamoto, Kazuhiko Kitagawa, Ryoko Takao
  • METHOD FOR PREVENTING OR TREATING OSTEOPOROSIS, CHARACTERIZED BY ADMINISTERING TERIPARATIDE OR SALT THEREOF AT A FREQUENCY OF TWICE A WEEK
    Publication number: 20210260166
    Abstract: [Problems] To provide a method for treating and/or preventing osteoporosis with teriparatide or a salt thereof, the method having excellent safety and/or efficacies. [Solving Means] A method for treating and/or preventing osteoporosis in which teriparatide or a salt thereof is an active ingredient, including administering teriparatide or a salt thereof in a unit dose of 28.2 ?g at a frequency of twice a week.
    Type: Application
    Filed: May 7, 2021
    Publication date: August 26, 2021
    Applicant: ASAHI KASEI PHARMA CORPORATION
    Inventors: Takeshi MINAMIDA, Ryo KATO, Akira KOIKE, Atsushi OSE, Akihiro KITAMI, Takashi MAKIYAMA, Hikaru YAMAMOTO, Kazuhiko KITAGAWA, Ryoko TAKAO
  • METHOD FOR PREVENTING OR TREATING OSTEOPOROSIS, CHARACTERIZED BY ADMINISTERING TERIPARATIDE OR SALT THEREOF AT A FREQUENCY OF TWICE A WEEK
    Publication number: 20210077590
    Abstract: [Problems] To provide a method for treating and/or preventing osteoporosis with teriparatide or a salt thereof, the method having excellent safety and/or efficacies. [Solving Means] A method for treating and/or preventing osteoporosis in which teriparatide or a salt thereof is an active ingredient, including administering teriparatide or a salt thereof in a unit dose of 28.2 ?g at a frequency of twice a week.
    Type: Application
    Filed: November 25, 2020
    Publication date: March 18, 2021
    Applicant: ASAHI KASEI PHARMA CORPORATION
    Inventors: Takeshi MINAMIDA, Ryo KATO, Akira KOIKE, Atsushi OSE, Akihiro KITAMI, Takashi MAKIYAMA, Hikaru YAMAMOTO, Kazuhiko KITAGAWA, Ryoko TAKAO
  • TERIPARATIDE-CONTAINING LIQUID PHARMACEUTICAL COMPOSITION HAVING EXCELLENT PHARMACOKINETICS AND/OR SAFETY
    Publication number: 20200289622
    Abstract: A liquid pharmaceutical preparation for subcutaneous administration in human containing 28.2 ?g of teriparatide or a salt thereof (Component 1) in a unit dose in terms of teriparatide, wherein the Component 1 concentration is from 80 to 240 ?g/mL. This liquid pharmaceutical preparation is excellent in the viewpoint of pharmacokinetics.
    Type: Application
    Filed: September 20, 2018
    Publication date: September 17, 2020
    Applicant: ASAHI KASEI PHARMA CORPORATION
    Inventors: Kohei MIYABE, Atsushi OSE, Yuki SATO, Toshiyuki KODAMA, Yasuhiro MATSUNAWA, Hikaru YAMAMOTO